# A Study to Evaluate the Safety Following Injection of GP0045 Compared to Restylane Lyft Lidocaine

> **NCT03133325** · NA · COMPLETED · sponsor: **Galderma R&D** · enrollment: 12 (actual)

## Conditions studied

- Safety

## Interventions

- **DEVICE:** GP0045
- **DEVICE:** Restylane Lyft Lidocaine

## Key facts

- **NCT ID:** NCT03133325
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-19
- **Primary completion:** 2017-07-13
- **Final completion:** 2017-07-13
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03133325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03133325, "A Study to Evaluate the Safety Following Injection of GP0045 Compared to Restylane Lyft Lidocaine". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03133325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*